Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease
- 1 October 2001
- journal article
- review article
- Published by Elsevier BV in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 25 (7), 1341-1357
- https://doi.org/10.1016/s0278-5846(01)00192-0
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Activated Microglial Cells Are Colocalized With Perivascular Deposits of Amyloid-β Protein in Alzheimer’s Disease BrainStroke, 1997
- Oxidative damage in Alzheimer'sNature, 1996
- Inhibition of NF-κB by Pyrrolidine Dithiocarbamate Blocks Endothelial Cell ActivationBiochemical and Biophysical Research Communications, 1995
- Structural basis of potent antiperoxidation activity of the triterpene celastrol in mitochondria: Effect of negative membrane surface charge on lipid peroxidationFree Radical Biology & Medicine, 1994
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- Reactive microglia/macrophages phagocytose amyloid precursor protein produced by neurons following neural damageJournal of Neuroscience Research, 1992
- Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brainExperimental Neurology, 1990
- The triterpene celastrol as a very potent inhibitor of lipid peroxidation in mitochondriaBiochemical and Biophysical Research Communications, 1990
- Cytotoxic diterpenes triptolide, tripdiolide, and cytotoxic triterpenes from tissue cultures of Tripterygium wilfordiiCanadian Journal of Chemistry, 1981
- Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.The Journal of cell biology, 1980